| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/25/2007 | WO2007011285A1 Therapeutic agents |
| 01/25/2007 | WO2007011284A1 Therapeutic agents |
| 01/25/2007 | WO2007010999A1 Animal in which lipid metabolism and sugar metabolism are modified by krap gene mutation, modification method and modifying agent |
| 01/25/2007 | WO2007010976A1 Body weight gain inhibitory composition comprising d-psicose and use thereof |
| 01/25/2007 | WO2007010975A1 Use of psicose in agent for prevention of the increase in blood d-fructose level |
| 01/25/2007 | WO2007010974A1 Use of antihypergycemic effect of d-allose |
| 01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 01/25/2007 | WO2007010546A1 Compounds for treatment of lipase-mediated diseases |
| 01/25/2007 | WO2007010390A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007010337A2 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 01/25/2007 | WO2007010217A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS |
| 01/25/2007 | WO2007009911A1 PYRIDO [2 , 3-D] PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS |
| 01/25/2007 | WO2007009799A1 Amino acid salts of rosiglitazone |
| 01/25/2007 | WO2007009724A2 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009723A2 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009722A1 Octahydropentalene-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009721A2 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009720A2 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009709A1 Cycloalkane-substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009705A1 (rac)-n-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydr0-1h-pyrazole-3-carboxamide hydrates |
| 01/25/2007 | WO2007009700A2 Use of substituted pyrazoline compounds for the treatment of the lipid parameters of the metabolic syndrome |
| 01/25/2007 | WO2007009698A1 Combination of pyrazoline type cannabinoid receptor antagonist and statin |
| 01/25/2007 | WO2007009696A1 Use of substituted pyrazoline compounds for the preparation of paediatric medicaments |
| 01/25/2007 | WO2007009694A1 Use of substituted pyrazoline compounds for the preparation of medicaments for the treatment of metabolic syndrome |
| 01/25/2007 | WO2007009693A1 Combination of a substituted pyrazoline compound and a drug used in food-related disorders |
| 01/25/2007 | WO2007009692A1 Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| 01/25/2007 | WO2007009690A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009689A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009688A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 01/25/2007 | WO2007009687A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 01/25/2007 | WO2007009683A2 Pharmaceutical formulations of substituted pyrazoline compounds |
| 01/25/2007 | WO2007009655A1 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic |
| 01/25/2007 | WO2007009353A1 Substituted thiazol-4-one compounds, preparation methods and use thereof |
| 01/25/2007 | WO2007009236A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/25/2007 | WO2007009194A1 Sra binding protein |
| 01/25/2007 | WO2006130080A3 Quinoline derivatives as nk3 anatgonists |
| 01/25/2007 | WO2006121861A3 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/25/2007 | WO2006117696A3 Diastereoisomers of 4-hydroxyisoleucine and uses thereof |
| 01/25/2007 | WO2006114439A3 Novel nutraceutical compositions |
| 01/25/2007 | WO2006074330A3 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 01/25/2007 | WO2006028839A3 Delta 6-desaturase genes and uses thereof |
| 01/25/2007 | US20070021589 Obesity-related genes |
| 01/25/2007 | US20070021509 Phosphate transport inhibitors |
| 01/25/2007 | US20070021491 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 01/25/2007 | US20070021483 Amidine derivatives for treating amyloidosis |
| 01/25/2007 | US20070021478 Benzothiazolyl derivatives |
| 01/25/2007 | US20070021477 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021474 Heterocyclically Substituted Benzoylureas, Process For Their Preparation and Their Use as Pharmaceuticals |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021428 2-Substituted phenyl-1,3-dihydropyrazolo(4,3-c)cinnolines, e.g., N-[3-(tert-butyl-methyl-amino)-butyl]-4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-benzamide, are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28, used for treating autoimmune diseases |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070020231 Remedy for kidney diseases |
| 01/25/2007 | DE102005033630A1 Calcium-Peptid-Komponente Calcium peptide component |
| 01/25/2007 | DE102005033100B3 Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung New 1,4-benzothiazepine-1,1-Dioxidderivat with improved properties, these drug compound contained and processes for their preparation |
| 01/25/2007 | CA2616031A1 Amino acid salts of rosiglitazone |
| 01/25/2007 | CA2615588A1 Pyrazole derivatives as cb1 modulators |
| 01/25/2007 | CA2615045A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/25/2007 | CA2614963A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | CA2614697A1 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof |
| 01/25/2007 | CA2614585A1 Compounds for treatment of lipase-mediated diseases |
| 01/25/2007 | CA2614524A1 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic |
| 01/25/2007 | CA2614327A1 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 01/25/2007 | CA2612468A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2611366A1 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2611364A1 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/24/2007 | EP1746099A1 Mnk1 or Mnk2 inhibitors |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1746086A1 Cyanopyrrolidine derivatives |
| 01/24/2007 | EP1745790A2 Treatment of rumen acidosis with alpha-amylase inhibitors |
| 01/24/2007 | EP1745789A1 Compositions comprising ribose for increasing energy in vivo |
| 01/24/2007 | EP1745788A1 Acyglycerophospholipids for treating cancer and cachexia |
| 01/24/2007 | EP1745787A2 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1-alpha 25-dihydroxy Vitamin D3 |
| 01/24/2007 | EP1745782A1 Use of substitued pyrazoline compounds for the preparation of medicaments for the treatment of metabolic syndrome |
| 01/24/2007 | EP1745781A1 Combination of pyrazoline type cannabinoid receptor antagonist and statin |
| 01/24/2007 | EP1745779A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass |
| 01/24/2007 | EP1745003A1 Novel compounds, their preparation and use |
| 01/24/2007 | EP1745002A1 Novel compounds, their preparation and use |
| 01/24/2007 | EP1744774A2 Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite |
| 01/24/2007 | EP1744772A1 Flaxseeds for body weight management |
| 01/24/2007 | EP1744737A2 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 01/24/2007 | EP1744729A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/24/2007 | EP1461070B1 Combined use of a glp-1 compound and an aldose reductase inhibitor |
| 01/24/2007 | EP1123414B1 Antisense modulation of integrin alpha 4 expression |
| 01/24/2007 | EP1056845B1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 01/24/2007 | EP1040102B1 Arylthiazolidinedione derivatives |
| 01/24/2007 | EP1003777B1 PGC-1, A NOVEL BROWN FAT PPARgamma COACTIVATOR |
| 01/24/2007 | CN1902189A Plant-origin beta3-adrenoceptor agonist and use of the same |
| 01/24/2007 | CN1902177A Novel piperidine derivative |
| 01/24/2007 | CN1902172A N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders |
| 01/24/2007 | CN1902169A 4-biarylyl-1-phenylazetidin-2-ones |
| 01/24/2007 | CN1901938A Combination of a DPP-IV inhibitor and an anti-obesity or appetite regulating agent |
| 01/24/2007 | CN1901927A Alpha-glucosidase activity inhibitor |